Trending Topic

2 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

From advances in targeted therapies to the integration of AI and steps towards precision medicine, 2024 brought many exciting developments in the field. With 2025 now unfolding, many of these are likely to continue gaining momentum and potentially redefine patient care. In this latest edition of touchREVIEWS in RMD, we’re excited to present a collection […]

Su Lwin: Epidermolysis Bullosa and Gene Therapy (Part 2)

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jan 26th 2021

It was lovely to speak to our Expert Faculty member, Su Lwin (King’s College London, London, UK), about the development and clinical application of gene and cell therapy for individuals with epidermolysis bullosa.

Questions

  1. Could you tell us a little about your research into spray-on gene therapy for recessive dystrophic epidermolysis bullosa? (0:18)
  2. Could you tell us a little about the study you are involved in on intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa? (2:03)
  3. What other novel approaches would you like to highlight? (4:35)

Part 1 of our discussion can be viewed here.

Disclosures: Su Lwin had nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup